146 related articles for article (PubMed ID: 11384234)
1. 3D-QSAR model of flavonoids binding at benzodiazepine site in GABAA receptors.
Huang X; Liu T; Gu J; Luo X; Ji R; Cao Y; Xue H; Wong JT; Wong BL; Pei G; Jiang H; Chen K
J Med Chem; 2001 Jun; 44(12):1883-91. PubMed ID: 11384234
[TBL] [Abstract][Full Text] [Related]
2. The use of a pharmacophore model for identification of novel ligands for the benzodiazepine binding site of the GABAA receptor.
Kahnberg P; Howard MH; Liljefors T; Nielsen M; Nielsen EØ; Sterner O; Pettersson I
J Mol Graph Model; 2004 Dec; 23(3):253-61. PubMed ID: 15530821
[TBL] [Abstract][Full Text] [Related]
3. Molecular modeling and QSAR analysis of the interaction of flavone derivatives with the benzodiazepine binding site of the GABA(A) receptor complex.
Marder M; Estiú G; Blanch LB; Viola H; Wasowski C; Medina JH; Paladini AC
Bioorg Med Chem; 2001 Feb; 9(2):323-35. PubMed ID: 11249125
[TBL] [Abstract][Full Text] [Related]
4. An updated unified pharmacophore model of the benzodiazepine binding site on gamma-aminobutyric acid(a) receptors: correlation with comparative models.
Clayton T; Chen JL; Ernst M; Richter L; Cromer BA; Morton CJ; Ng H; Kaczorowski CC; Helmstetter FJ; Furtmüller R; Ecker G; Parker MW; Sieghart W; Cook JM
Curr Med Chem; 2007; 14(26):2755-75. PubMed ID: 18045122
[TBL] [Abstract][Full Text] [Related]
5. GABA(A)-receptor ligands of flavonoid structure.
Marder M; Paladini AC
Curr Top Med Chem; 2002 Aug; 2(8):853-67. PubMed ID: 12171576
[TBL] [Abstract][Full Text] [Related]
6. 3D-pharmacophores of flavonoid binding at the benzodiazepine GABA(A) receptor site using 4D-QSAR analysis.
Hong X; Hopfinger AJ
J Chem Inf Comput Sci; 2003; 43(1):324-36. PubMed ID: 12546568
[TBL] [Abstract][Full Text] [Related]
7. The Benzodiazepine Binding Sites of GABA
Sigel E; Ernst M
Trends Pharmacol Sci; 2018 Jul; 39(7):659-671. PubMed ID: 29716746
[TBL] [Abstract][Full Text] [Related]
8. Refinement and evaluation of a pharmacophore model for flavone derivatives binding to the benzodiazepine site of the GABA(A) receptor.
Kahnberg P; Lager E; Rosenberg C; Schougaard J; Camet L; Sterner O; Østergaard Nielsen E; Nielsen M; Liljefors T
J Med Chem; 2002 Sep; 45(19):4188-201. PubMed ID: 12213060
[TBL] [Abstract][Full Text] [Related]
9. QSAR modeling of the interaction of flavonoids with GABA(A) receptor.
Duchowicz PR; Vitale MG; Castro EA; Autino JC; Romanelli GP; Bennardi DO
Eur J Med Chem; 2008 Aug; 43(8):1593-602. PubMed ID: 18158201
[TBL] [Abstract][Full Text] [Related]
10. Photoaffinity labeling of the benzodiazepine binding site of alpha1beta3gamma2 gamma-aminobutyric acidA receptors with flunitrazepam identifies a subset of ligands that interact directly with His102 of the alpha subunit and predicts orientation of these within the benzodiazepine pharmacophore.
McKernan RM; Farrar S; Collins I; Emms F; Asuni A; Quirk K; Broughton H
Mol Pharmacol; 1998 Jul; 54(1):33-43. PubMed ID: 9658187
[TBL] [Abstract][Full Text] [Related]
11. Comparative quantitative structure-activity relationship studies (QSAR) on non-benzodiazepine compounds binding to benzodiazepine receptor (BzR).
Hadjipavlou-Litina D; Garg R; Hansch C
Chem Rev; 2004 Sep; 104(9):3751-94. PubMed ID: 15352779
[No Abstract] [Full Text] [Related]
12. Studies of molecular pharmacophore/receptor models for GABAA/benzodiazepine receptor subtypes: binding affinities of substituted beta-carbolines at recombinant alpha x beta 3 gamma 2 subtypes and quantitative structure-activity relationship studies via a comparative molecular field analysis.
Huang Q; Cox ED; Gan T; Ma C; Bennett DW; McKernan RM; Cook JM
Drug Des Discov; 1999 Jul; 16(1):55-76. PubMed ID: 10466057
[TBL] [Abstract][Full Text] [Related]
13. Selective influence on contextual memory: physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the alpha5 subunit.
Harris D; Clayton T; Cook J; Sahbaie P; Halliwell RF; Furtmüller R; Huck S; Sieghart W; DeLorey TM
J Med Chem; 2008 Jul; 51(13):3788-803. PubMed ID: 18537233
[TBL] [Abstract][Full Text] [Related]
14. Development of a 3D pharmacophore for nonspecific ligand recognition of alpha1, alpha2, alpha3, alpha5, and alpha6 containing GABA(A)/benzodiazepine receptors.
Filizola M; Harris DL; Loew GH
Bioorg Med Chem; 2000 Jul; 8(7):1799-807. PubMed ID: 10976528
[TBL] [Abstract][Full Text] [Related]
15. Predictive models for GABAA/benzodiazepine receptor subtypes: studies of quantitative structure-activity relationships for imidazobenzodiazepines at five recombinant GABAA/benzodiazepine receptor subtypes [alphaxbeta3gamma2 (x = 1-3, 5, and 6)] via comparative molecular field analysis.
Huang Q; Liu R; Zhang P; He X; McKernan R; Gan T; Bennett DW; Cook JM
J Med Chem; 1998 Oct; 41(21):4130-42. PubMed ID: 9767648
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for ligand recognition at the benzodiazepine binding site of GABAA alpha 3 receptor, and pharmacophore-based virtual screening approach.
Vijayan RS; Ghoshal N
J Mol Graph Model; 2008 Oct; 27(3):286-98. PubMed ID: 18565775
[TBL] [Abstract][Full Text] [Related]
17. Pharmacophore, 3D-QSAR, and Bayesian model analysis for ligands binding at the benzodiazepine site of GABAA receptors: the key roles of amino group and hydrophobic sites.
Yang Y; Zhang W; Cheng J; Tang Y; Peng Y; Li Z
Chem Biol Drug Des; 2013 May; 81(5):583-90. PubMed ID: 23279907
[TBL] [Abstract][Full Text] [Related]
18. Pseudoreceptor models and 3D-QSAR for imidazobenzodiazepines at GABA A/BzR subtypes alphaxbeta3gamma2 [x = 1-3, 5, and 6] via flexible atom receptor model.
Lu A; Zhou J
J Chem Inf Comput Sci; 2004; 44(3):1130-6. PubMed ID: 15154782
[TBL] [Abstract][Full Text] [Related]
19. Local intersection volume: a new 3D descriptor applied to develop a 3D-QSAR pharmacophore model for benzodiazepine receptor ligands.
Verli H; Albuquerque MG; Bicca de Alencastro R; Barreiro EJ
Eur J Med Chem; 2002 Mar; 37(3):219-29. PubMed ID: 11900866
[TBL] [Abstract][Full Text] [Related]
20. Neuroactive flavonoids interacting with GABAA receptor complex.
Wang F; Shing M; Huen Y; Tsang SY; Xue H
Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):575-85. PubMed ID: 16266290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
